Drug Development Consultant & Regulatory Consultant


Regulators Publish Draft Guidance for industry on Risk Evaluation and Mitigation Strategies (REMS)

Regulators, FDA CDER Publish Draft Guidance for industry on Risk Evaluation and Mitigation Strategies (REMS)

full text here

This document provides guidance to industry on:

  • The format and content of a proposed risk evaluation and mitigation strategy (REMS), including REMS supporting documentation;
  • The content of assessments and proposed modifications of approved REMS;
  • What identifiers to use on REMS documents; and
  • How to communicate with FDA about a REMS.

The information on the content of a proposed REMS submission (section III of this document) also applies to proposed REMS that are voluntarily submitted by applicants or holders of approved applications (see section II.A of this document).

This guidance will address REMS elements and provisions that are broadly applicable to proposed REMS and to assessments and modifications of approved REMS. Other provisions,  such as those that pertain only to abbreviated new drug applications (ANDAs), or expanded information about REMS assessments and proposed modifications, will not be fully addressed, but will be the subject of future guidance.

If you would like more detail in this area please get in touch with Damien Bové damien.bove@idaconsultants.com

Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

How To Write A Business Plan

Turn your Business Into an Investor Magnet

How to Write a Business Plan – Free E-Course

Get the secrets that turns your project into an investment magnet, 100% of our clients raise the finance they need to take their projects to the next stage, we will share these secrets with you. – Sign up for Free

Grow your Expertise for Free

As you know this website is a great resource for keeping up to date with developments and regulations, why not get our FREE monthly regulatory and market round up. You can un-subscribe at any time and we do not share your details with anybody.

First name

E-mail address

This guideline ap
recombinant vaccines for the prevention and treatment of infectious disease, and provides guidance on quality, non-clinical and clinical aspects.
Free Strategy Consultation - Biotech Pharma Regualtory

Leave a Comment

(required)

(required)

Formatting Your Comment

The following XHTML tags are available for use:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

URLs are automatically converted to hyperlinks.